title: Radiation-induced neuropathy in cancer survivors.
abstract: Radiation-induced peripheral neuropathy is a chronic handicap, frightening because progressive and usually irreversible, usually appearing several years after radiotherapy. Its occurrence is rare but increasing with improved long-term cancer survival. The pathophysiological mechanisms are not yet fully understood. Nerve compression by indirect extensive radiation-induced fibrosis plays a central role, in addition to direct injury to nerves through axonal damage and demyelination and injury to blood vessels by ischaemia following capillary network failure. There is great clinical heterogeneity in neurological presentation since various anatomic sites are irradiated. The well-known frequent form is radiation-induced brachial plexopathy (RIBP) following breast cancer irradiation, while tumour recurrence is easier to discount today with the help of magnetic resonance imaging and positron emission tomography. RIBP incidence is in accordance with the irradiation technique, and ranges from 66% RIBP with 60Gy in 5Gy fractions in the 1960s to less than 1% with 50Gy in 2Gy fractions today. Whereas a link with previous radiotherapy is forgotten or difficult to establish, this has recently been facilitated by a posteriori conformal radiotherapy with 3D-dosimetric reconstitution: lumbosacral radiculo-plexopathy following testicular seminoma or Hodgkin's disease misdiagnosed as amyotrophic lateral sclerosis. Promising treatments via the antioxidant pathway for radiation-induced fibrosis suggest a way to improve the everyday quality of life of these long-term cancer survivors.
authors.affiliation: Oncologie-Radiothérapie, Hôpital saint Louis, APHP, Paris, France. sylvie.delanian@sls.aphp.fr
authors.forename: Sylvie
authors.initials: S
authors.lastname: Delanian
authors.forename: Jean-Louis
authors.initials: JL
authors.lastname: Lefaix
authors.forename: Pierre-François
authors.initials: PF
authors.lastname: Pradat
mesh_terms: D000975:Antioxidants / Q000627:therapeutic use; D020516:Brachial Plexus Neuropathies / Q000209:etiology; D001943:Breast Neoplasms / Q000532:radiotherapy; D018450:Disease Progression; D005260:Female; D005602:France / Q000453:epidemiology; D006689:Hodgkin Disease / Q000532:radiotherapy; D006801:Humans; D015994:Incidence; D009369:Neoplasms / Q000532:radiotherapy*; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology*; D011788:Quality of Life; D011832:Radiation Injuries / Q000209:etiology; D011878:Radiotherapy / Q000009:adverse effects; D017741:Survivors / Q000706:statistics & numerical data; D016896:Treatment Outcome
chemical_list: D000975:Antioxidants